WHO Launches Initiatives For Ebola POC Tests
This article was originally published in The Gray Sheet
Executive Summary
The World Health Organization has initiated a rapid review process and is providing early test validation materials to encourage more manufacturers to quickly develop rapid, point-of-care Ebola tests. Meanwhile, Aethlon Medical is providing its bio-filtration device to treat blood of Ebola patients.
You may also be interested in...
FDA Expands Aethlon Hemopurifier IDE To Address Ebola
The agency approved an expanded clinical trial allowing Aethlon to test an Ebola treatment protocol at 10 U.S. sites; requires the company to gain institutional review board approval from each institution and the trials can only enroll up to 20 patients.
FDA Emergency Authorizes Roche Ebola Assay
FDA grants its seventh Ebola diagnostic EUA, this time to Roche, as global health officials continue efforts to try to contain the outbreak of the deadly disease in West Africa.
Treating Ebola And Beyond: Spotlight On Novel Hemopurifier
Aethlon Medical’s Hemopurifier device was successfully used in Germany to treat a Ugandan physician with Ebola, and now the company is preparing to launch its first human clinical studies in the US. Aethlon hopes this novel device will provide a first-in-class broad-spectrum treatment countermeasure against pandemic threats such as Ebola and chronic viral pathogens.